En vivo

BioPharma DiveCeliac disease is entering a new era of therapeutic innovation BioPharma DivePlanning a successful pivot from lab to clinic Endpoints NewsHMNC Brain Health raises $50M Series B to advance two depression drugs eLifeNuclear CK1δ as a critical determinant of PER:CRY complex dynamics and circadian period JIANGSU KANGJIAN MEDICAL APPARATUS CO.,LTD.World Cryo-Preservation Vial System - Market Analysis, Forecast, Size, Trends and Insights - IndexBox BioWorldViva in vivo! At EHA, in vivo CAR T data continues to impress IlluminaWhat is proteomics? A simple guide to understanding measuring proteins at scale - Illumina Brady CorporationWorld Biohazard Spill Kits - Market Analysis, Forecast, Size, Trends and Insights - IndexBox Fritsch GmbHWorld Laser Diffraction Optical Units - Market Analysis, Forecast, Size, Trends and Insights - IndexBox TSI IncorporatedHot Wire Anemometers Market Growth Outlook to 2035: Innovation and Regulatory Tailwinds - News and Statistics - IndexBox Novo NordiskNovo Nordisk’s CagriSema Breakthrough Expands Growth Story Beyond Diabetes and Obesity - simplywall.st MKS NewportCenters Receive Awards for Nanoscale Research | light speed | Feb 2002 - Photonics Spectra

Endpoints News 15 jun 2026

HMNC Brain Health raises $50M Series B to advance two depression drugs

HMNC Brain Health has secured $50 million in a Series B fundraise designed to support two psychiatry programs into mid-stage studies. The family-owned German dr...

HMNC Brain Health has secured $50 million in a Series B fundraise designed to support two psychiatry programs into mid-stage studies. The family-owned German drugmaker Medice led the Series B, which was also backed by ...